We provide custom peptide–synthetic polymer conjugation services to support discovery, formulation development,
and preclinical programs. All constructs are supplied for research and non-human use unless otherwise agreed in writing. Typical goals include improving aqueous solubility, proteolytic stability,
circulation time, and enabling multivalent display or triggered behavior through polymer and linker design
[1], [4].
Projects are planned around site-defined attachment (when feasible) to reduce heterogeneity and preserve peptide activity.
Common attachment strategies include N-terminus or single-Cys targeting, as well as orthogonal handle-enabled approaches (e.g., azide/alkyne)
[2].
We support a broad set of polymer architectures—PEG and PEG alternatives, biodegradable synthetic polymers,
dendrimer scaffolds (PAMAM, G0–G10), and stimuli-responsive polymer/linker systems—with fit-for-purpose analytics
selected for the polymer class and intended application
[1], [3],
[4].
See also: Related services for peptide–drug conjugation, lipidation, and site-specific modification options.
PEG & PEG alternatives
Biodegradable polymers
Dendrimers (PAMAM G0-G10)
Stimuli-responsive linkers
Site-defined attachment
45+ years of expertise
U.S. facilities (Texas)
Figure: PAMAM dendrimer–peptide conjugation.
Representative schematic illustrating multivalent peptide attachment to a PAMAM dendrimer surface via linker-mediated conjugation.